Newsroom

Miniature TIC
Vidéos

[ANTIBIOGO] Antibiogo : A free diagnostic aid application to counter antibiotic resistance.

Événements

The MSF Foundation will be present at Vivatech from June 15 to 18

The MSF Foundation will be at Viva Technology 2022 - June 15 to 18 in Paris. You will find Antibiogo on the Google.org booth.

Read more
App Antibiogo
Articles

After 5 years of development, Antibiogo becomes the first medical device with CE marking developed by the MSF Foundation!

Read more
Événements

Discover the work of the MSF Foundation at ChangeNow

At ChangeNow, on Friday, May 20 at 10 a.m., Dr. Nada Malou will present Antibiogo in the "Big Innovations that will change Health" session.

Read more
Articles

Dr Nada Malou's intervention at the DIHAD 2022 conference

DIHAD is considered the first humanitarian and development event in the Middle East and has been bringing together leading humanitarian actors, government emergency management agencies, foundations and others since 2004. On the occasion of the 18th conference held from March 14-16, 2022, Dr Nada Malou presented Antibiogo.

 

Read more
KoutialaLab
Vidéos

Antibiogo launch of the latest clinical evaluation in Mali

Headline

MSF Foundation in Video

  • UneBragaEN
    Vidéos

    Back from the field Elizabeth Braga, physiotherapist was in Jahun, Nigeria, for the MSF Foundation.

  • WPC Dubai 2023 fondation msf
    Vidéos

    The MSF Foundation 3D program at the WPC World Physiotherapy Congress in Dubai

  • AI4CC qu'est-ce que c'est
    Vidéos

    AI4CC (Artificial intelligence for cervical cancer), what is it?

News

  • Articles

    Cervical cancer : when AI helps improve diagnosis

    Cervical cancer is the second deadliest cancer in low- and middle-income countries (1). In Malawi in East Africa, where MSF operates, over 4,000 Malawian women fall sick with cervical cancer every year. With 2,905 deaths due to cervical cancer in 2020, the country also had the second highest rate of mortality (2). How can we explain such a high mortality rate from this disease which, in high-income countries, is easily preventable and generally less deadly?  The reasons include limited access to prevention and screening, and diagnoses that are not always reliable.

     

    Clara Nordon, Director of the MSF Foundation, has just got back from a visit to Malawi with the MSF teams and tells us about the project led by the Foundation. Code name: AI4CC

    Read more
  • Utilisation d'Antibiogo au laboratoire MSF, hôpital CHK.Kinshasa. République Démocratique du Congo
    Articles

    Antibiogo is already implemented in routine in DRC and Jordan, and soon within other MSF’s Labs !

    Read more

Publications

  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.